Revolution Medicines, Inc. (RVMD)
210.02
-0.85
(-0.40%)
USD |
NASDAQ |
Sep 04, 16:00
209.26
-0.76
(-0.36%)
After-Hours: 20:00
Revolution Medicines SG&A Expense (TTM) : 330.91M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 330.91M |
| March 31, 2026 | 261.28M |
| December 31, 2025 | 195.04M |
| September 30, 2025 | 156.57M |
| June 30, 2025 | 127.76M |
| March 31, 2025 | 108.90M |
| December 31, 2024 | 96.72M |
| September 30, 2024 | 100.75M |
| June 30, 2024 | 92.31M |
| March 31, 2024 | 85.24M |
| December 31, 2023 | 75.62M |
| September 30, 2023 | 54.29M |
| June 30, 2023 | 49.21M |
| March 31, 2023 | 44.77M |
| December 31, 2022 | 40.58M |
| September 30, 2022 | 38.37M |
| Date | Value |
|---|---|
| June 30, 2022 | 35.72M |
| March 31, 2022 | 32.82M |
| December 31, 2021 | 30.45M |
| September 30, 2021 | 27.58M |
| June 30, 2021 | 25.13M |
| March 31, 2021 | 22.93M |
| December 31, 2020 | 21.43M |
| September 30, 2020 | 19.76M |
| June 30, 2020 | 17.53M |
| March 31, 2020 | 15.16M |
| December 31, 2019 | 12.41M |
| September 30, 2019 | 12.08M |
| June 30, 2019 | 8.976M |
| March 31, 2019 | 6.251M |
| December 31, 2018 | 3.835M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tango Therapeutics, Inc. | 56.51M |
| Erasca, Inc. | 41.80M |
| Moderna, Inc. | 965.00M |
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Intellia Therapeutics, Inc. | 136.25M |